Insights

Market gap Wound-down archival page for Ivy Natal highlights a niche in fertility tech focused on converting skin cells into genetically viable eggs, signaling a potential market for licensing or collaboration in next-gen reproductive technologies with researchers, biotech firms, or fertility clinics.

Funding signal Reported funding of 1.8M and revenue under 1M suggest limited current commercial traction but potential for partnerships, grants, or investment to advance IP, regulatory pathways, and pilot programs with established biotech players.

Tech readiness Tech stack indicates cloud, data storage, and web platforms that could be compatible with scalable biotech software, data security, and patient-facing interfaces, presenting opportunities to offer integration, cloud optimization, or compliance services.

Industry fit Competitive landscape includes fertility and lactation-focused players; potential sales angles include collaboration on donor egg alternatives, genetic lineage capabilities, and services attractive to clinics seeking innovative fertility solutions.

Go-to-market needs Archived status implies a need for revival, licensing, or partnership strategies to monetize IP; sales opportunities exist in identifying co-development partners, regulatory experts, and strategic investors to bring the concept to market.

Similar companies to Ivy Natal

Ivy Natal Tech Stack

Ivy Natal uses 8 technology products and services including Amazon Web Services, Amazon S3, cdnjs, and more. Explore Ivy Natal's tech stack below.

Ivy Natal's Email Address Formats

Ivy Natal uses at least 1 email format:
Ivy Natal Email FormatsExamplePercentage
First@ivynatal.comJohn@ivynatal.com
100%

Frequently Asked Questions

What is Ivy Natal's official website and social media links?

Minus sign iconPlus sign icon
Ivy Natal's official website is ivynatal.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Ivy Natal generate?

Minus sign iconPlus sign icon
As of September 2026, Ivy Natal's annual revenue is estimated to be <$1M.

What is Ivy Natal's SIC code and NAICS code?

Minus sign iconPlus sign icon
Ivy Natal's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ivy Natal have currently?

Minus sign iconPlus sign icon
As of September 2026, Ivy Natal has approximately 1 employees across 1 continents, including North America. Key team members include Director: M. N. Explore Ivy Natal's employee directory with LeadIQ.

What industry does Ivy Natal belong to?

Minus sign iconPlus sign icon
Ivy Natal operates in the Biotechnology Research industry.

What technology does Ivy Natal use?

Minus sign iconPlus sign icon
Ivy Natal's tech stack includes Amazon Web Services, Amazon S3, cdnjs, Squarespace, Amazon Route 53, Squarespace Commerce, Google Workspace and HSTS.

What is Ivy Natal's email format?

Minus sign iconPlus sign icon
Ivy Natal's email format typically follows the pattern of First@ivynatal.com. Find more Ivy Natal email formats with LeadIQ.

How much funding has Ivy Natal raised to date?

Minus sign iconPlus sign icon
As of September 2026, Ivy Natal has raised $1.8M in funding. The last funding round occurred on Jan 01, 2022 for $1.5M.

When was Ivy Natal founded?

Minus sign iconPlus sign icon
Ivy Natal was founded in 2020.
Ivy Natal logo

Ivy Natal

Biotechnology ResearchCalifornia, United States0-1 Employees

Ivy Natal is a biotechnology research company based in San Francisco, California, focused on enabling genetic reproduction for individuals who cannot have children with their own eggs. The firm describes a process that begins with a skin biopsy to transform skin cells into healthy egg cells by directly activating the cells’ existing DNA, aiming to overcome challenges associated with conventional in vitro methods for producing eggs and sperm. Its work targets women who face infertility due to factors such as surgery, chemotherapy, aging, or genetic conditions, with the broader objective of expanding the ability to have genetic children, including for same-sex couples. The company positions itself within the biotechnology research sector, addressing reproductive genetics and fertility options. Ivy Natal operates with a small team, and is located in San Francisco, offering its research focus to potential patients and partners seeking new avenues in family planning and genetic parenthood. }

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
0-1

Section iconFunding & Financials

  • $1.8M

    Ivy Natal has raised a total of $1.8M of funding over 2 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $1.5M as a Venture Round.

  • <$1M

    Ivy Natal's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.